One such recurrent genetic mutation occurring in approximately 2% of acute myeloid leukemia (AML) patients is del(9q), which is enriched in patients with the t(8∶21) fusion protein AML1-ETO[2]. Here, RUNX1 is linked to acute myeloid leukemia.